LUNGevity

LUNGevity Foundation is the nation’s leading lung cancer organization focused on improving outcomes for people with lung cancer through research, policy initiatives, education, support, and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.

Join us this November for Lung Cancer Awareness Month and put lung cancer on the national stage! https://www.lungevity.org/lcam

Latest from LUNGevity

ctDNA-Guided Treatment De-escalation Feasible in Advanced NSCLC

August 09, 2024

Article

One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.

LUNGevity Foundation Expands Its Board to Accelerate Transforming Lung Cancer

July 23, 2024

Article

Four newly inducted members represent the lived experience of lung cancer, advocacy, health equity, and business leadership.

‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC

April 30, 2024

Article

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

No Questions for Nurses Off-Limits for Patients with Lung Cancer

March 13, 2024

Video

As part of its Speaking Out video series, CURE® spoke with Lisa Carter-Bawa of Hackensack Meridian Health about the role nurses play in helping patients manage treatment side effects.

Lung Cancer ‘Leading the Charge in Precision Medicine’

March 13, 2024

Video

As part of its Speaking Out video series, CURE® spoke with Upal Basu Roy of LUNGevity about recently approved treatments for lung cancer and what is on the horizon.

Chemo Shortage Didn’t Materialize ‘The Way We Initially Feared’

March 13, 2024

Video

As part of its Speaking Out video series, CURE® spoke with Amy C. Moore of LUNGevity about the chemotherapy shortage and its impact on patients with lung cancer.